CSL Limited Sponsored ADR (OTCMKTS:CSLLY - Get Free Report) shares fell 0.2% during mid-day trading on Thursday . The stock traded as low as $86.82 and last traded at $87.04. 66,125 shares were traded during mid-day trading, an increase of 31% from the average session volume of 50,391 shares. The stock had previously closed at $87.21.
CSL Stock Up 1.8%
The company has a quick ratio of 0.85, a current ratio of 1.86 and a debt-to-equity ratio of 0.45. The firm's 50 day moving average is $81.07 and its 200-day moving average is $80.52.
CSL Company Profile
(
Get Free Report)
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.
Featured Stories
Before you consider CSL, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CSL wasn't on the list.
While CSL currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
